Journal of Renal Nutrition
Volume 6, Issue 4 , Page 236 , October 1996

Ask CRN

References 

  1. Allen EM, Buss DC, Williams J, et al.  The effect of activated charcoal on mouse sleep times induced by intravenously administered hypnotics. Biopharm Drug Dispos. 1986;7:421–429
  2. Karkkainen S, Neuvonen PJ. Pharmacokinetics of amitriptyline influenced by oral charcoal and urine pH. Int J Clin Pharmacol Ther Toxicol. 1986;24:326–332
  3. Karkkainen S, Neuvonen PJ. Effect of oral charcoal and urine pH on dextropoxphene pharmacokinetics. Int J Clin Pharmacol Ther Toxicol. 1985;23:219–225
  4. Bachrach WH, Hofmann AF. Ursodeoxycholic acid in the treatment of cholesterol cholelithiases (Part I). Dig Dis Sci. 1982;27:737–761
  5. Chyka PA, Holley JE, Mandrell TD, et al.  Correlation of drug pharmacokinetics and effectiveness of multiple dose activated charcoal therapy. Ann Emerg Med. 1995;25:356–362
  6. Van Ness Chattau. Flatulence: Pathophysiology and treatment. Am Fam Physician. 1985;31:198–208

PII: S1051-2276(96)90073-4

Journal of Renal Nutrition
Volume 6, Issue 4 , Page 236 , October 1996

Article Tools